207 related articles for article (PubMed ID: 27754760)
1. Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer.
Zheng Y; Yang Y; Wu S; Zhu Y; Tang X; Liu X
Bioengineered; 2017 Jul; 8(4):367-373. PubMed ID: 27754760
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus.
Zhu Y; Zheng Y; Mei L; Liu M; Li S; Xiao H; Zhu H; Wu S; Chen H; Huang L
Int J Oncol; 2013 Oct; 43(4):1151-9. PubMed ID: 23877655
[TBL] [Abstract][Full Text] [Related]
3. The Antitumor Activity of CAR-T-PD1 Cells Enhanced by HPV16mE7-Pulsed and SOCS1-Silenced DCs in Cervical Cancer Models.
Zheng J; Huang J; Ma W; Yang W; Hu B
Cancer Manag Res; 2021; 13():6045-6053. PubMed ID: 34377023
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
[TBL] [Abstract][Full Text] [Related]
5. Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.
Shi S; Wang R; Chen Y; Song H; Chen L; Huang G
PLoS One; 2013; 8(6):e65757. PubMed ID: 23799045
[TBL] [Abstract][Full Text] [Related]
6. Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.
Wu Y; Deng Z; Wang H; Ma W; Zhou C; Zhang S
BMC Immunol; 2016 Sep; 17(1):29. PubMed ID: 27645787
[TBL] [Abstract][Full Text] [Related]
7. Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.
van Poelgeest MI; Visconti VV; Aghai Z; van Ham VJ; Heusinkveld M; Zandvliet ML; Valentijn AR; Goedemans R; van der Minne CE; Verdegaal EM; Trimbos JB; van der Burg SH; Welters MJ
Cancer Immunol Immunother; 2016 Dec; 65(12):1451-1463. PubMed ID: 27619514
[TBL] [Abstract][Full Text] [Related]
8. Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer.
Jeon YH; Lee HW; Lee YL; Kim JE; Hwang MH; Jeong SY; Lee SW; Ahn BC; Ha JH; Lee J
Cancer Biother Radiopharm; 2011 Dec; 26(6):671-9. PubMed ID: 22091632
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.
Shi S; Tao L; Song H; Chen L; Huang G
APMIS; 2014 May; 122(5):380-91. PubMed ID: 24628659
[TBL] [Abstract][Full Text] [Related]
10. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model.
Kim HM; Lim J; Kang JS; Park SK; Lee K; Kim JY; Kim YJ; Hong JT; Kim Y; Han SB
Int Immunopharmacol; 2009 Mar; 9(3):375-80. PubMed ID: 19105981
[TBL] [Abstract][Full Text] [Related]
12. Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas.
Ryu JI; Han MH; Cheong JH; Kim JM; Kim CH
Immunotherapy; 2017 Mar; 9(5):411-421. PubMed ID: 28357913
[TBL] [Abstract][Full Text] [Related]
13. An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.
Rice AE; Latchman YE; Balint JP; Lee JH; Gabitzsch ES; Jones FR
Cancer Gene Ther; 2015 Sep; 22(9):454-62. PubMed ID: 26337747
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells.
Ye JF; Lin YQ; Yu XH; Liu MY; Li Y
Int Immunopharmacol; 2016 Sep; 38():460-7. PubMed ID: 27380620
[TBL] [Abstract][Full Text] [Related]
15. Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model.
Huang X; Huang G; Song H; Chen L
Int J Cancer; 2011 Aug; 129(3):648-58. PubMed ID: 20878978
[TBL] [Abstract][Full Text] [Related]
16. Combined Treatment with Autologous CIK Cells, Radiotherapy and Chemotherapy in Advanced Cervical Cancer.
Li N; Tian YW; Xu Y; Meng DD; Gao L; Shen WJ; Liu ZL; Xu ZQ
Pathol Oncol Res; 2019 Apr; 25(2):691-696. PubMed ID: 30511107
[TBL] [Abstract][Full Text] [Related]
17. Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer.
de Jong A; van der Hulst JM; Kenter GG; Drijfhout JW; Franken KL; Vermeij P; Offringa R; van der Burg SH; Melief CJ
Int J Cancer; 2005 Mar; 114(2):274-82. PubMed ID: 15540211
[TBL] [Abstract][Full Text] [Related]
18. Retargeted human avidin-CAR T cells for adoptive immunotherapy of EGFRvIII expressing gliomas and their evaluation via optical imaging.
Liu K; Liu X; Peng Z; Sun H; Zhang M; Zhang J; Liu S; Hao L; Lu G; Zheng K; Gong X; Wu D; Wang F; Shen L
Oncotarget; 2015 Sep; 6(27):23735-47. PubMed ID: 26124178
[TBL] [Abstract][Full Text] [Related]
19. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
[TBL] [Abstract][Full Text] [Related]
20. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]